Apellis Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
APLS Nasdaq 2830 www.apellis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Apellis Pharmaceuticals, Inc.

Apellis Shares Rise After Reporting Preliminary Q4, Full-Year Product Sales Results - Jan 13th, 2025 7:23 pm
Apellis Highlights Commercial Growth and Strategic Priorities at 43rd Annual J.P. Morgan Healthcare Conference - Jan 13th, 2025 2:00 pm
Apellis Announces Keli Walbert to Join the Board of Directors - Jan 10th, 2025 12:00 pm
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 7th, 2025 9:05 pm
Apellis Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 6th, 2025 12:00 pm
Exploring 3 High Growth Tech Stocks In The United States - Jan 3rd, 2025 6:02 pm
Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue? - Dec 12th, 2024 4:30 pm
Should You Hold Apellis Pharmaceuticals (APLS)? - Dec 12th, 2024 2:35 pm
Why Is Amicus Therapeutics (FOLD) Down 11.1% Since Last Earnings Report? - Dec 6th, 2024 4:31 pm
Why Is Apellis Pharmaceuticals (APLS) Up 18.4% Since Last Earnings Report? - Dec 5th, 2024 4:30 pm
Exploring Three High Growth Tech Stocks in the United States - Dec 4th, 2024 2:07 pm
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences - Nov 27th, 2024 12:00 pm
Apellis Pharmaceuticals to Host a Fireside Chat at the Jefferies London Healthcare Conference - Nov 12th, 2024 12:00 pm
Apellis price target lowered to $30 from $43 at Wells Fargo - Nov 7th, 2024 11:31 am
Apellis price target lowered to $47 from $61 at BofA - Nov 7th, 2024 11:25 am
Apellis' Q3 Loss Wider Than Expected, Syfovre Drives Revenues Y/Y - Nov 6th, 2024 4:34 pm
Apellis Pharmaceuticals Inc (APLS) Q3 2024 Earnings Call Highlights: Revenue Surge and ... - Nov 6th, 2024 7:10 am
Why Apellis Pharmaceuticals Stock Was Tumbling on Tuesday - Nov 5th, 2024 9:47 pm
Apellis Pharmaceuticals (APLS) Reports Q3 Earnings: What Key Metrics Have to Say - Nov 5th, 2024 2:30 pm
High Growth Tech Stocks to Watch in November 2024 - Nov 5th, 2024 2:07 pm